Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare.  With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York.  That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. 

In 2003, that company would become X-GEN Pharmaceuticals, Inc.  Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals.  

In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.

Health Care

Pharmaceutical

XGen Pharmaceuticals DJB

Susan Badia

Rob Liles

Rick Pfeiffer

Marcus Juliano, MBA

Kimberly Johnson

Jordan Liles

Ed Vanderbeck

Catherine Liles

The Quality Assurance and Compliance team at XGen Pharmaceuticals DJB is responsible for ensuring that all products meet rigorous quality standards and adhere to regulatory requirements. This involves implementing and monitoring compliance programs, conducting audits, and overseeing quality assurance practices at external manufacturing facilities. Their work ensures the consistent delivery of safe and effective pharmaceuticals, upholding the company's commitment to quality and reliability.

Quality Assurance and Compliance

Leadership Team

Operations Team

Quality Assurance and Compliance

About

Team members

Other teams at XGen Pharmaceuticals DJB

Leadership Team

Operations Team